Clik here to view.
DelMar closes $9m public offering
DelMar Pharmaceuticals (NSDQ:DMPI) closed its $9 million public offering today. Earlier this week, the company priced 2.8 million shares and warrants to purchase an aggregate of 2.1 million shares of...
View ArticleClik here to view.
GE shares slide despite posting Street-beating Q1
Shares in General Electric (NYSE:GE) fell today despite the industrial conglomerate beating expectations on The Street and posting solid gains for its healthcare division. GE reported profits of $577...
View ArticleClik here to view.
Hospira, Baxter subpoenaed in antitrust probe over intravenous saline
Drugmakers received grand jury subpoenas from the U.S. Justice Dept. this week in connection with an antitrust probe into companies that market intravenous saline solutions. ICU Medical (NSDQ:ICUI),...
View ArticleClik here to view.
Revolutions CEO Wheet found not guilty of fraud charges
Revolutions Medical CEO Ron Wheet has been found not guilty of allegations of filing false stock registration statements, according to Charleston, S.C.’s Post & Courier. The case was based around...
View ArticleClik here to view.
7 medtech stories we missed this week: April 21, 2017
[Image from unsplash.com]From new and renewed partnerships to FDA approvals, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Life Spine receives FDA clearance...
View ArticleClik here to view.
Beaver-Visitec picks up Malosa Medical
Beaver-Visitec said today it acquired U.K.-based single-use ophthalmology surgical instrument maker Malosa Medical for an undisclosed amount. Malosa Medical has a portfolio of more than 400 products,...
View ArticleClik here to view.
The 10 hottest medtech startups of 2017
Medtech startups face more challenges than they have in the past, but several companies are developing products that take advantage of new technology and are specifically designed to meet healthcare’s...
View ArticleClik here to view.
6 ways hydrogels are enabling medtech innovation
[Image from University of Delaware]Hydrogels are water-based biomaterials developed specifically for human use, according to a Biomaterials journal article. They are a water-swollen polymeric material...
View ArticleClik here to view.
How IBM is using deep learning to detect diabetic eye disease
IBM’s deep learning technology can detect and classify the severity of diabetic retinopathy with 86% accuracy, according to new research. The diagnostic tool could help doctors and physicians better...
View ArticleClik here to view.
The Immortal Life of Henrietta Lacks
[Image from Oregon State University on Flickr]On Saturday, April 22nd, HBO will premiere their film “The immortal Life of Henrietta Lacks.” We are excited to see the film and thought we would...
View ArticleClik here to view.
Stryker launches new facility featuring “OR of the Future”
Stryker (NYSE:SYK) said this week it opened a new customer experience center in San Jose, Calif, featuring a high-tech “Operating Room of the Future.” The company’s OR display includes integration of...
View ArticleClik here to view.
Mallinckrodt, Marathon leave industry trade group over drug pricing controversy
Marathon Pharmaceuticals reportedly withdrew from the drug industry’s lobbying group yesterday following controversy over its pricey drug, Emflaza. Pharmaceutical Research and Manufacturers of America...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for April 21, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Study: Gamida Cell’s NiCord cell graft yields fewer infections, shorter...
Gamida Cell said today that its NiCord cell graft produces fewer infections, shorter hospital stays and shorter time to engraftment compared to standard umbilical cord blood transplantation. The...
View ArticleClik here to view.
Cellnovo, Diabeloop launch artificial pancreas CE Mark trial
Cellnovo (EPA:CLNV) and Diabeloop said this week they are launching a CE Mark cross-over registration study for an artificial pancreas device Diabeloop is developing which uses Cellnovo’s insulin pump....
View ArticleClik here to view.
Abbott CEO White optimistic on Alere buy
Abbott (NYSE:ABT) CEO Miles White is optimistic about the company’s upcoming acquisition of Alere despite previous concerns and attempts to sink the deal, according to a SeekingAlpha transcript of the...
View ArticleClik here to view.
Stimwave wins 5-year DoD contract to supply SCS devices
Stimwave Technologies said today it won a Distribution and Pricing Agreement with the Department of Defense’s Defense Logistics Agency. Through the 5-year contract, Stimwave will supply the Agency...
View ArticleClik here to view.
This test can detect tiny ovarian tumors sooner than current tests
[Image from Nephron/CC BY-SA 3.0]Massachusetts Institute of Technology engineers have developed a way to detect ovarian tumors that are smaller than 2 mm in diameter, allowing for detection 5 months...
View ArticleClik here to view.
7D Surgical inks US distro deals for spinal surgery system
Canadian medical device firm 7D Surgical said today it inked exclusive US distribution deals with Surgical One and DB Surgical. Through the deal, Surgical One will cover sales of the devices in...
View ArticleClik here to view.
3Shape wins expanded FDA nod for Ortho System orthodontic software suite
Orthodontic med device firm 3Shape said last Friday it won expanded FDA 510(k) clearance for its 3Shape Ortho System software for orthodontics. The expanded indications allow for the designing of...
View Article